Fact CheckerSign in

NCT05755594Not yet recruiting

A Prospective Study on the Safety and Efficacy of Robot-assisted Pancreaticoduodenectomy

Source: ClinicalTrials.gov · Last updated 6 Mar 2023 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Further studies are needed to investigate the prognosis and perioperative safety of patients undergoing robotic-assisted pancreaticoduodenectomy. In this study, clinical data and prognostic data of patients undergoing this procedure were prospectively collected and analyzed to explore its safety and efficacy.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
100 (estimated)
First submitted
23 Feb 2023
Start date
1 Jun 2023
Primary completion date
1 Jun 2028
Lead sponsor
The First Affiliated Hospital of University of South China
NCT number
NCT05755594

What you commit to

  • Study type: Interventional
  • Planned participants: 100
  • From 1 Jun 2023 to the primary completion date, 1 Jun 2028
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients found intraoperative peripheral organ metastasis combined with excision of other organs or found intraoperative radical excision could not be performed and underwent palliative drainage surgery or end the surgery
  • Preoperative adjuvant therapy was given

Other illness

  • Patients unable to tolerate anesthesia and operation due to serious abnormalities in functions of heart, lung and other important organs

Other

  • With tumors of other organs

Who the study is looking for

  • Over 18 years old
  • Preoperative imaging suggested the presence of space occupying in the head of the pancreas, ampullary abdomen, and distal common bile duct tumor lesions to be treated with Pancreaticoduodenectomy
  • No distant transfer
  • No significant vascular invasion was received

Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.